95
Participants
Start Date
September 17, 2022
Primary Completion Date
August 31, 2029
Study Completion Date
August 31, 2029
VIR-2218
VIR-2218 given by subcutaneous injection
VIR-3434
VIR-3434 given by subcutaneous injection
NRTI
NRTI given orally.
Investigative Site, Auckland
Investigative Site, Sofia
Investigative Site, Sofia
Investigative Site, Stara Zagora
Investigative Site, Milan
Investigative Site, Hanover
Investigative Site, Toulouse
Investigative Site, Pessac
Investigative Site, Rennes
Investigative Site, Pisa
Investigative Site, Frankfurt
Investigative Site, Tübingen
Investigative Site, Clichy
Investigative Site, Chisinau
Investigative Site, Rotterdam
Investigative Site, Bucharest
Investigative Site, Birmingham
Investigative Site, London
Investigative Site, London
Investigative Site, Manchester
Vir Biotechnology, Inc.
INDUSTRY